$EW
Edwards Lifesciences Corp Stock $ew

$ew Overview Financials Valuation SEC Filings Company Website

2018 Q1 Form 10-Q Financial Statement

#000109980018000012 Filed on April 27, 2018

Income Statement

Concept	2018 Q1	2017 Q1
Revenue	$894.8M	$883.5M
YoY Change	1.28%	26.7%
Cost Of Revenue	$233.6M	$215.6M
YoY Change	8.35%	19.58%
Gross Profit	$661.2M	$667.9M
YoY Change	-1.0%	29.19%
Gross Profit Margin	73.89%	75.6%
Selling, General & Admin	$256.0M	$229.6M
YoY Change	11.5%	7.95%
% of Gross Profit	38.72%	34.38%
Research & Development	$143.2M	$128.7M
YoY Change	11.27%	26.42%
% of Gross Profit	21.66%	19.27%
Depreciation & Amortization	$19.10M	$21.10M
YoY Change	-9.48%	32.7%
% of Gross Profit	2.89%	3.16%
Operating Expenses	$399.2M	$358.3M
YoY Change	11.42%	13.93%
Operating Profit	$252.5M	$298.3M
YoY Change	-15.35%	47.31%
Interest Expense	-$4.800M	$2.400M
YoY Change	-300.0%	0.0%
% of Operating Profit	-1.9%	0.8%
Other Income/Expense, Net	$3.100M	-$2.300M
YoY Change	-234.78%	-42.5%
Pretax Income	$263.5M	$293.6M
YoY Change	-10.25%	60.17%
Income Tax	$56.90M	$63.40M
% Of Pretax Income	21.59%	21.59%
Net Earnings	$206.6M	$230.2M
YoY Change	-10.25%	60.98%
Net Earnings / Revenue	23.09%	26.06%
Basic Earnings Per Share	$0.98	$1.09
Diluted Earnings Per Share	$0.96	$1.06
COMMON SHARES
Basic Shares Outstanding	210.2M shares	211.2M shares
Diluted Shares Outstanding	215.1M shares	216.4M shares

Balance Sheet

Concept	2018 Q1	2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.499B	$918.2M
YoY Change	63.29%	-3.53%
Cash & Equivalents	$1.227B	$819.3M
Short-Term Investments	$272.3M	$98.90M
Other Short-Term Assets	$118.9M	$105.6M
YoY Change	12.59%	43.48%
Inventory	$573.9M	$431.4M
Prepaid Expenses	$78.00M	$53.00M
Receivables	$406.6M	$510.2M
Other Receivables	$40.20M	$0.00
Total Short-Term Assets	$2.717B	$2.018B
YoY Change	34.61%	10.94%
LONG-TERM ASSETS
Property, Plant & Equipment	$711.6M	$588.8M
YoY Change	20.86%	18.4%
Goodwill	$1.145B	$945.2M
YoY Change	21.12%	49.82%
Intangibles	$480.5M	$402.1M
YoY Change	19.5%	97.4%
Long-Term Investments	$4.300M	$4.600M
YoY Change	-6.52%	-33.33%
Other Assets	$57.80M	$127.8M
YoY Change	-54.77%	-2.52%
Total Long-Term Assets	$3.108B	$2.762B
YoY Change	12.53%	35.76%
TOTAL ASSETS
Total Short-Term Assets	$2.717B	$2.018B
Total Long-Term Assets	$3.108B	$2.762B
Total Assets	$5.825B	$4.780B
YoY Change	21.85%	24.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$121.2M	$93.00M
YoY Change	30.32%	18.32%
Accrued Expenses	$385.3M	$347.0M
YoY Change	11.04%	11.11%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$598.6M
YoY Change
Total Short-Term Liabilities	$1.315B	$584.8M
YoY Change	124.78%	27.6%
LONG-TERM LIABILITIES
Long-Term Debt	$456.0M	$847.9M
YoY Change	-46.22%	40.8%
Other Long-Term Liabilities	$321.8M	$409.4M
YoY Change	-21.4%	-17.13%
Total Long-Term Liabilities	$777.8M	$1.257B
YoY Change	-38.14%	14.7%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.315B	$584.8M
Total Long-Term Liabilities	$777.8M	$1.257B
Total Liabilities	$2.092B	$2.038B
YoY Change	2.68%	31.08%
SHAREHOLDERS EQUITY
Retained Earnings	$2.179B	$4.146B
YoY Change	-47.44%	19.14%
Common Stock	$1.442B	$1.451B
YoY Change	-0.6%	23.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$254.2M	$2.672B
YoY Change	-90.49%	22.53%
Treasury Stock Shares	2.300M shares	32.80M shares
Shareholders Equity	$3.246B	$2.743B
YoY Change
Total Liabilities & Shareholders Equity	$5.825B	$4.780B
YoY Change	21.85%	24.04%

Cashflow Statement

Concept	2018 Q1	2017 Q1
OPERATING ACTIVITIES
Net Income	$206.6M	$230.2M
YoY Change	-10.25%	60.98%
Depreciation, Depletion And Amortization	$19.10M	$21.10M
YoY Change	-9.48%	32.7%
Cash From Operating Activities	$151.3M	$128.3M
YoY Change	17.93%	19.79%
INVESTING ACTIVITIES
Capital Expenditures	$43.20M	$15.90M
YoY Change	171.7%	-42.6%
Acquisitions	$0.00	$82.00M
YoY Change	-100.0%
Other Investing Activities	-$600.0K	-$600.0K
YoY Change	0.0%	-85.71%
Cash From Investing Activities	$220.3M	$151.2M
YoY Change	45.7%	219.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$2.100M	$437.4M
YoY Change	-99.52%	27.11%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$40.90M	-$391.3M
YoY Change	-110.45%	6.01%
NET CHANGE
Cash From Operating Activities	$151.3M	$128.3M
Cash From Investing Activities	$220.3M	$151.2M
Cash From Financing Activities	$40.90M	-$391.3M
Net Change In Cash	$412.5M	-$111.8M
YoY Change	-468.96%	-47.93%
FREE CASH FLOW
Cash From Operating Activities	$151.3M	$128.3M
Capital Expenditures	$43.20M	$15.90M
Free Cash Flow	$108.1M	$112.4M
YoY Change	-3.83%	41.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	674100000	USD
CY2018Q1	ew	Proceedsfrom Paymentsto Trading Securities Heldforinvestment ProceedsfromPaymentstoTradingSecuritiesHeldforinvestment	-3100000	USD
CY2017Q4	ew	Researchand Development Accruals ResearchandDevelopmentAccruals	39200000	USD
CY2018Q1	dei	Amendment Flag AmendmentFlag	false
CY2018Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2018Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018Q1	dei	Document Period End Date DocumentPeriodEndDate	2018-03-31
CY2018Q1	dei	Document Type DocumentType	10-Q
CY2018Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001099800
CY2018Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	210779115	shares
CY2018Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2018Q1	dei	Entity Registrant Name EntityRegistrantName	Edwards Lifesciences Corp
CY2017Q4	ew	Accrual For Property Payroll And Other Taxes Other Than Income Taxes Current AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent	41900000	USD
CY2018Q1	ew	Accrual For Property Payroll And Other Taxes Other Than Income Taxes Current AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent	46500000	USD
CY2017Q4	ew	Accrued Rebates AccruedRebates	53900000	USD
CY2018Q1	ew	Accrued Rebates AccruedRebates	49400000	USD
CY2017Q4	ew	Accrued Relocation Costs Current AccruedRelocationCostsCurrent	8700000	USD
CY2018Q1	ew	Accrued Relocation Costs Current AccruedRelocationCostsCurrent	10600000	USD
CY2017Q4	ew	Cumulative Income Loss From Equity Method Investments CumulativeIncomeLossFromEquityMethodInvestments	-5100000	USD
CY2018Q1	ew	Cumulative Income Loss From Equity Method Investments CumulativeIncomeLossFromEquityMethodInvestments	-4900000	USD
CY2018Q1	ew	Loss Contingency Claims That If Settled Could Have A Material Adverse Impact Number LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber	1	lawsuit
CY2017Q1	ew	Proceedsfrom Paymentsto Trading Securities Heldforinvestment ProceedsfromPaymentstoTradingSecuritiesHeldforinvestment	-4400000	USD
CY2018Q1	ew	Researchand Development Accruals ResearchandDevelopmentAccruals	46000000	USD
CY2018Q1	ew	Tax Cuts And Jobs Act Measurement Period Adjustment Transition Tax For Accumulated Foreign Earnings Income Tax Expense Benefits TaxCutsAndJobsActMeasurementPeriodAdjustmentTransitionTaxForAccumulatedForeignEarningsIncomeTaxExpenseBenefits	-8300000	USD
CY2017	ew	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Asset Provisional Income Tax Expense Benefit TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit	-3300000	USD
CY2017	ew	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Foreign Tax Credits Provisional Income Tax Expense Benefit TaxCutsAndJobsActOf2017IncompleteAccountingForeignTaxCreditsProvisionalIncomeTaxExpenseBenefit	-32300000	USD
CY2018Q1	ew	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Transition Tax For Accumulated Foreign Earnings Provisional Income Tax Expense Benefit TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit	24000000	USD
CY2017	ew	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Transition Tax For Accumulated Foreign Earnings Provisional Income Tax Expense Benefit Gross TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefitGross	327400000	USD
CY2017Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	753200000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	116600000	USD
CY2018Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	121200000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	421600000	USD
CY2018Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	406600000	USD
CY2017Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	97800000	USD
CY2018Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	125100000	USD
CY2017Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	14900000	USD
CY2018Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	18200000	USD
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	8500000	USD
CY2018Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	6300000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-132700000	USD
CY2018Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-121300000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1166900000	USD
CY2018Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1229100000	USD
CY2017Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15200000	USD
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18400000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8500000	USD
CY2018Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	9000000	USD
CY2017Q4	us-gaap	Assets Assets	5649300000	USD
CY2018Q1	us-gaap	Assets Assets	5825100000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	2532100000	USD
CY2018Q1	us-gaap	Assets Current AssetsCurrent	2716900000	USD
CY2017Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	800000	USD
CY2018Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	800000	USD
CY2017Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2900000	USD
CY2018Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	6300000	USD
CY2017Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	685300000	USD
CY2018Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	642400000	USD
CY2017	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses	1200000	USD
CY2018Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses	1700000	USD
CY2017	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Aggregate Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses	2900000	USD
CY2018Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Aggregate Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses	6300000	USD
CY2017Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	504800000	USD
CY2018Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	485200000	USD
CY2017	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses	1700000	USD
CY2018Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses	4600000	USD
CY2017Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	385300000	USD
CY2018Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	370600000	USD
CY2017Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	119500000	USD
CY2018Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	114600000	USD
CY2018Q1	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis	126300000	USD
CY2018Q1	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	125900000	USD
CY2018Q1	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis	410000000	USD
CY2018Q1	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	405800000	USD
CY2018Q1	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	106100000	USD
CY2018Q1	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	105200000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	683200000	USD
CY2018Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	636900000	USD
CY2017Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1100000	USD
CY2018Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	3800000	USD
CY2017Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	51700000	USD
CY2018Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	41800000	USD
CY2017Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	192600000	USD
CY2018Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	196300000	USD
CY2017Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	12800000	USD
CY2018Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	15800000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	930100000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	819300000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	818300000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1227000000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-110800000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	408700000	USD
CY2018Q1	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	-13000000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2018Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2018Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	212000000	shares
CY2018Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	213000000	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	209700000	shares
CY2018Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	210700000	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	212000000	USD
CY2018Q1	us-gaap	Common Stock Value CommonStockValue	213000000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	247100000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	218000000	USD
CY2017Q4	us-gaap	Cost Method Investments CostMethodInvestments	10700000	USD
CY2018Q1	us-gaap	Cost Method Investments CostMethodInvestments	13500000	USD
CY2017Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	215600000	USD
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	233600000	USD
CY2017Q4	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	94000000	USD
CY2018Q1	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	96100000	USD
CY2017Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	167100000	USD
CY2018Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	181400000	USD
CY2017Q4	us-gaap	Deferred Revenue DeferredRevenue	4200000	USD
CY2018Q1	us-gaap	Deferred Revenue DeferredRevenue	5300000	USD
CY2018Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	600000	USD
CY2017Q1	us-gaap	Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments	0	USD
CY2018Q1	us-gaap	Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments	7100000	USD
CY2017Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	21100000	USD
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19100000	USD
CY2017Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	24800000	USD
CY2018Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	25900000	USD
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.09
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.98
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.06
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.96
CY2017Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	1000000	USD
CY2018Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-3800000	USD
CY2017Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.216
CY2018Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.216
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	249400000	USD
CY2018Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	140200000	USD
CY2018Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	96500000	USD
CY2018Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P26M
CY2017Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	9200000	USD
CY2018Q1	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	9200000	USD
CY2017Q4	us-gaap	Equity Method Investments EquityMethodInvestments	4100000	USD
CY2018Q1	us-gaap	Equity Method Investments EquityMethodInvestments	4300000	USD
CY2018Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	3800000	USD
CY2018Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	0	USD
CY2018Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	10000000	USD
CY2017Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	244300000	USD
CY2018Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	238100000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	1126500000	USD
CY2018Q1	us-gaap	Goodwill Goodwill	1144800000	USD
CY2017Q1	us-gaap	Gross Profit GrossProfit	667900000	USD
CY2018Q1	us-gaap	Gross Profit GrossProfit	661200000	USD
CY2017Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	388200000	USD
CY2018Q1	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	149700000	USD
CY2017Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	0	USD
CY2018Q1	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	0	USD
CY2018Q1	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	0	USD
CY2018Q1	us-gaap	Held To Maturity Securities Debt Maturities Next Rolling Twelve Months Fair Value HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	146400000	USD
CY2018Q1	us-gaap	Held To Maturity Securities Debt Maturities Rolling Year Two Through Five Fair Value HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	0	USD
CY2018Q1	us-gaap	Held To Maturity Securities Debt Maturities Without Single Maturity Date Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	3300000	USD
CY2018Q1	us-gaap	Held To Maturity Securities Debt Maturities Without Single Maturity Date Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount	3300000	USD
CY2017Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	388200000	USD
CY2018Q1	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	149700000	USD
CY2018Q1	us-gaap	Heldtomaturity Securities Debt Maturities Next Rolling Twelve Months Amortized Cost HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost	146400000	USD
CY2018Q1	us-gaap	Heldtomaturity Securities Debt Maturities Rolling Year Two Through Five Amortized Cost HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost	0	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	293600000	USD
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3300000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	263500000	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	63400000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	56900000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	81500000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-29900000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-94200000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-118000000	USD
CY2017Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	19000000	USD
CY2018Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-6700000	USD
CY2017Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-36600000	USD
CY2018Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-31100000	USD
CY2017Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	24300000	USD
CY2017Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-3700000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	4200000	USD
CY2017Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3600000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	26400000	USD
CY2017Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	5200000	shares
CY2018Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4900000	shares
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	468000000	USD
CY2018Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	480500000	USD
CY2017Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2400000	USD
CY2018Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	800000	USD
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	332400000	USD
CY2018Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	334200000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	554900000	USD
CY2018Q1	us-gaap	Inventory Net InventoryNet	573900000	USD
CY2017Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	101400000	USD
CY2018Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	108000000	USD
CY2017Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	121100000	USD
CY2018Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	131700000	USD
CY2017Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	14800000	USD
CY2018Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	17800000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5649300000	USD
CY2018Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5825100000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1402900000	USD
CY2018Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1314500000	USD
CY2017Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	15000000	USD
CY2018Q1	us-gaap	Litigation Reserve Current LitigationReserveCurrent	16600000	USD
CY2017Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	10200000	USD
CY2018Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	5700000	USD
CY2017Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	598000000	USD
CY2018Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	598600000	USD
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	438400000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	74300000	USD
CY2018Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	456000000	USD
CY2017Q4	us-gaap	Long Term Investments LongTermInvestments	567000000	USD
CY2018Q1	us-gaap	Long Term Investments LongTermInvestments	532100000	USD
CY2018Q1	us-gaap	Maximum Length Of Time Foreign Currency Cash Flow Hedge MaximumLengthOfTimeForeignCurrencyCashFlowHedge	P13M
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-391300000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	40900000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	151200000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	220300000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	128300000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	151300000	USD
CY2017Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	230200000	USD
CY2018Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	206600000	USD
CY2017Q4	us-gaap	Noncurrent Assets NoncurrentAssets	784400000	USD
CY2018Q1	us-gaap	Noncurrent Assets NoncurrentAssets	765000000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	298300000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	252500000	USD
CY2018Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	66600000	USD
CY2017Q4	us-gaap	Other Assets Current OtherAssetsCurrent	116900000	USD
CY2018Q1	us-gaap	Other Assets Current OtherAssetsCurrent	118900000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	108900000	USD
CY2018Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	57800000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	6600000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-6300000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-12600000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	23700000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	28400000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	16900000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	11400000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	0	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-300000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-500000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-1400000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-200000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1000000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-6100000	USD
CY2017Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	88400000	USD
CY2018Q1	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	94400000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	311700000	USD
CY2018Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	321800000	USD
CY2017Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	600000	USD
CY2018Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1000000	USD
CY2017Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2300000	USD
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3100000	USD
CY2017Q4	us-gaap	Other Receivables OtherReceivables	40600000	USD
CY2018Q1	us-gaap	Other Receivables OtherReceivables	40200000	USD
CY2017Q1	us-gaap	Payment For Contingent Consideration Liability Investing Activities PaymentForContingentConsiderationLiabilityInvestingActivities	0	USD
CY2018Q1	us-gaap	Payment For Contingent Consideration Liability Investing Activities PaymentForContingentConsiderationLiabilityInvestingActivities	10000000	USD
CY2017Q1	us-gaap	Payments For Proceeds From Businesses And Interest In Affiliates PaymentsForProceedsFromBusinessesAndInterestInAffiliates	-200000	USD
CY2018Q1	us-gaap	Payments For Proceeds From Businesses And Interest In Affiliates PaymentsForProceedsFromBusinessesAndInterestInAffiliates	1800000	USD
CY2017Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-600000	USD
CY2018Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-600000	USD
CY2017Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	437400000	USD
CY2018Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2200000	USD
CY2017Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	167400000	USD
CY2018Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	0	USD
CY2017Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	82000000	USD
CY2018Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2017Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2700000	USD
CY2018Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3000000	USD
CY2017Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15900000	USD
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	43200000	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2018Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2018Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	60600000	USD
CY2018Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	78000000	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	377400000	USD
CY2018Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	5100000	USD
CY2017Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1000000	USD
CY2018Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1600000	USD
CY2017Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	193300000	USD
CY2018Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	42300000	USD
CY2017Q1	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	229500000	USD
CY2018Q1	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	238500000	USD
CY2017Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	23100000	USD
CY2018Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	44700000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	679700000	USD
CY2018Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	711600000	USD
CY2018Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	-4600000	USD
CY2017Q1	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	353400000	USD
CY2018Q1	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	5100000	USD
CY2017Q1	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	5600000	USD
CY2018Q1	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	0	USD
CY2017Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	128700000	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	143200000	USD
CY2017Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	8200000	USD
CY2018Q1	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	1500000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1962100000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2179100000	USD
CY2017Q1	us-gaap	Sales Revenue Net SalesRevenueNet	883500000	USD
CY2018Q1	us-gaap	Sales Revenue Net SalesRevenueNet	894800000	USD
CY2017Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	229600000	USD
CY2018Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	256000000	USD
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	15200000	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	18400000	USD
CY2017Q4	us-gaap	Short Term Investments ShortTermInvestments	519200000	USD
CY2018Q1	us-gaap	Short Term Investments ShortTermInvestments	272300000	USD
CY2017Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	266500000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	2956200000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	3245700000	USD
CY2017Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	347500000	USD
CY2018Q1	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	290800000	USD
CY2017Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2300000	shares
CY2018Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	2300000	shares
CY2017Q4	us-gaap	Treasury Stock Value TreasuryStockValue	252100000	USD
CY2018Q1	us-gaap	Treasury Stock Value TreasuryStockValue	254200000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	225600000	USD
CY2018Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	229300000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	131600000	USD
CY2018Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	133200000	USD
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	216400000	shares
CY2018Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	215100000	shares
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	211200000	shares
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	210200000	shares

Files In Submission

Name	View Source	Status
0001099800-18-000012-index-headers.html	Edgar Link	pending
0001099800-18-000012-index.html	Edgar Link	pending
0001099800-18-000012.txt	Edgar Link	pending
0001099800-18-000012-xbrl.zip	Edgar Link	pending
ew-20180331.xml	Edgar Link	completed
ew-20180331.xsd	Edgar Link	pending
ew-20180331_cal.xml	Edgar Link	unprocessable
ew-20180331_def.xml	Edgar Link	unprocessable
ew-20180331_lab.xml	Edgar Link	unprocessable
ew-20180331_pre.xml	Edgar Link	unprocessable
ew10-qq12018.htm	Edgar Link	pending
ew10-qq120_chartx55097a08.jpg	Edgar Link	pending
ew10-qq120_chartx56718a08.jpg	Edgar Link	pending
ew10-qq120_chartx58317a08.jpg	Edgar Link	pending
ew10-qq220_chartx39380a07.jpg	Edgar Link	pending
ew10-qq220_chartx39428a07.jpg	Edgar Link	pending
ew10-qq220_chartx40257a07.jpg	Edgar Link	pending
ew10-qq220_chartx40915a07.jpg	Edgar Link	pending
ew10-qq220_chartx40975a07.jpg	Edgar Link	pending
ew10-qq220_chartx43964a07.jpg	Edgar Link	pending
ew10-qq220_chartx45302a07.jpg	Edgar Link	pending
ew10-qq220_chartx46645a07.jpg	Edgar Link	pending
ex-10110xqq12018.htm	Edgar Link	pending
ex-31110xqq12018.htm	Edgar Link	pending
ex-31210xqq12018.htm	Edgar Link	pending
ex-3210xqq12018.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EW
Edwards Lifesciences Corp Stock $ew

2018 Q1 Form 10-Q Financial Statement

#000109980018000012 Filed on April 27, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EW Edwards Lifesciences Corp Stock $ew

2018 Q1 Form 10-Q Financial Statement

#000109980018000012 Filed on April 27, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EW
Edwards Lifesciences Corp Stock $ew